← Open Payments lookup

ZENATSEHAY GEBRETSADIK: Open Payments

NPI 1053087106 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,263 in 196 payments from 18 companies in 2025. Trend: 2023 $3,580 · 2024 $3,113 · 2025 $4,263

Food & beverage: $4,151Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.19$476
Lundbeck LLC22$413
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$411
ABBVIE INC.19$402
Vanda Pharmaceuticals Inc.13$343
Alkermes, Inc.20$340
Axsome Therapeutics, Inc.15$324
Neurocrine BioSciences, Inc.11$311
Janssen Pharmaceuticals, Inc10$284
Neos Therapeutics, LP8$174

Products named: CAPLYTA, VRAYLAR, FANAPT, ARISTADA, INGREZZA, Auvelity, REXULTI, AUSTEDO XR.

Industry payments across MD — which companies pay providers there.